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Abstract
Recent concern regarding the impact
of maternal drug abuse on neonatal well
being was the impetus for this
retrospective cohort study of newborns
diagnosed with neonatal abstinence
syndrome that were discharged from
Cabell Huntington Hospital during the
calendar year 2005. Medical records of
the neonates and their mothers were
analyzed for a variety of health related
outcomes and healthcare cost.
Forty-eight neonates were diagnosed
with Neonatal Abstinence Syndrome in
2005, forty of which required NICU
assistance. The average maternal age at
delivery was 26; gravity was 3.1 and most
were single, separated or divorced. The
majority had poor or inconsistent prenatal
care. Twenty-one delivered by cesarean
section most often for fetal distress. Most
delivered prematurely with an average
gestation of 35.9 weeks. Half of the
mothers went into preterm labor with half
of those having premature ruptured
membranes. Opiates were the most
common maternal substance found, while
neonates most often tested positive for
methadone. Nearly 90% of the mothers
smoked. Thirty-four of the mothers were
found to continue illicit drug abuse while
pregnant, while another eight were seen
in a methadone clinic for a history of
abuse. Most of the neonates required
weaning with methadone. The majority of
our study cases were funded by Medicaid,
mostly by West Virginia with total hospital
costs exceeding 1.7 million dollars. Direct
cost attributed to detoxification was in

excess of $180,000. The number of
neonates diagnosed with Neonatal
Abstinence Syndrome has nearly tripled
from 2003 to 2007.
The problem of maternal drug abuse
and addiction during pregnancy has
dramatic effects on both their unborn
children and our local healthcare system.
Increased awareness of this growing
problem is needed so that earlier
interventions can be implemented. It is
our opinion that all obstetrical patients at
risk should be screened early and often
so that those affected individuals can be
managed more aggressively to improve
neonatal outcomes.

Introduction
Neonatal Abstinence Syndrome
(NAS) consists of a group of
symptoms caused by neonatal
withdrawal from maternal use of
narcotics. The definition has also been
expanded to include other substances
(selective serotonin reuptake
inhibitors, nicotine, amphetamines,
marijuana, and alcohol). Incidence
has been difficult to ascertain due
to poor reporting of maternal drug
abuse, however, estimates range from
3 to 50% depending on the patient
population and area of the country
studied. At birth, the neonate’s drug
supply is lost, leading to withdrawal
within days to weeks depending
on the half-life of the substance,
maternal and fetal metabolism, and
hydration. As many as half of the
fetuses exposed to narcotics will
experience withdrawal; while long
term mortality is extremely low,
the risk of SIDS (sudden infant
death syndrome) is increased
by 3.7% in methadone users and
2.3% in cocaine users. Withdrawal
causes central nervous system over
stimulation as evidenced by highpitched cry, restless sleep lasting
less than 1-3 hours, hyper-reflexia,
tremors, increased muscular tone,

myoclonic jerks, and convulsions.
The gastrointestinal system is also
affected with excessive suckling,
poor feeding, regurgitation, emesis
(often projectile), and loose stools.
Metabolic, vasomotor and respiratory
effects include diaphoresis, fevers,
yawning, sneezing, nasal flaring,
respiratory rates often greater
than 60/min. (without retractions)
and apneic episodes. The rate of
intrauterine growth restriction,
preterm rupture of membranes,
preterm delivery, oligohydramnios,
low APGAR scores, meconium
staining and intrauterine fetal
demise are all increased. Infants
with NAS, as well as their mothers,
ultimately require greater care and
often longer hospitalizations with
many requiring neonatal intensive
care unit (NICU) assistance. The
cost impact of these interventions
nationwide is largely unknown. It
has been our observation that the
diagnosis of NAS has been increasing
in frequency in our NICU in the past
five years. It is not the intent of this
study to establish cause and effect
but rather to bring attention to the
scope and the potential impact of the
problem to our healthcare system.

Materials and Methods
A retrospective cohort study of
neonates discharged from Cabell
Huntington Hospital (CHH) was
performed during the calendar
year 2005 with the diagnoses of
NAS (N=48). CHH, an academic
tertiary care center in Huntington,
West Virginia, is the site of over
2500 live births yearly. The year
2005 was chosen so that all of
the records and billing would be
finalized and so that a comparison
of the number of affected neonates
with the two preceding and two
post characterization years could be
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made. Before initiating the study,
The Marshall University Institutional
Review Board approval was obtained.
To select the patient population,
the medical records department
compiled a list of all infants that
were discharged from our facility
during 2005 with an ICD-9 code
(779.5) for NAS. These neonate’s
charts were recovered and used to
identify their mothers whose charts
were also recovered. Information
was extracted from both the neonate
and mother’s charts. Fourteen of the
maternal charts were not available
for review since they delivered
at outlying facilities and only the
newborn infant was transported
to our facility. The neonate’s
chart, however, often contained
extensive maternal information.
CHH had 2549 live births in 2005.
Thirty-four (1.3%) of these neonates
were diagnosed with NAS. Some
required the services of the NICU
(N=26), while others were able to
go to the newborn nursery (N=8).
Our facility also provides NICU
services for the surrounding area
and receives neonatal transfers from
many outlying hospitals. From these,
another 14 babies were identified
with NAS during the time frame
of our study. The resulting study
population numbered 48 babies. Of
the 48, five were twins; therefore,
our study involved 46 mothers.
Data was extracted from the
neonates’ charts (N=48) as well as
the available maternal charts (N=32,
since 14 delivered elsewhere). This
information was recorded onto
standardized data collection forms by
the author. Items retrieved included

drugs used during pregnancy,
quality of prenatal care, insurance
status, maternal age, gravity and
parity, pregnancy and delivery
complications as well as the mode
of delivery. Other data collected
included the percent of expected
birth weight, gestation age at
delivery, postpartum complications,
and total hospital days, which
were divided into NICU, newborn
nursery and pediatric days. Maternal
information was recorded onto the
corresponding neonate’s data sheet.
To maintain confidentiality, the
data collection forms were coded
by numbering 1-48 corresponding
to the neonates in the study. All
patient identification information
was listed separately with the
corresponding codes and known only
to the author. The data collection
forms were maintained and stored
confidentially in the OB/GYN
office at Marshall University. The
code sheet was stored separately
by the author. Once the study
was completed, the identification
code sheet was shredded.
The drugs involved were
determined by examination of both
the neonate’s and their mother’s
charts. Maternal drugs were
identified by a positive maternal
drug screen, positive neonatal
urine, meconium testing, or
admission by the mother of using
a substance during her pregnancy.
Neonatal drugs were determined
only by positive testing of the
infant’s urine or meconium.
The total cost of hospitalization
for the 48 neonates was compiled by
the billing department of CHH. The

average cost of stay was calculated
by dividing the total by 48. A
comparison between the average cost
of stay of a healthy newborn with
the average cost of stay of a newborn
with NAS and no other health
issues was made. The difference
in the cost of caring for these two
neonates was the direct cost of
detoxification for the treatment of
NAS. This number was multiplied
by 48 for the total cost of care
directly attributed to detoxification.
Raw numbers of infants carrying
the diagnoses of NAS were obtained
(by ICD-9 code search by our medical
records department) for the two
years prior and two years after 2005.
Neither maternal nor neonate charts
were examined for this purpose.

Results
During the calendar year
2005, forty-eight neonates were
discharged with the diagnosis of
neonatal abstinence syndrome.
Of these, 33 were delivered at our
facility, 14 were transported to our
facility after being delivered at
outlying hospitals and 1 delivered
at home. Of the 33 delivering at
Cabell Huntington Hospital, 7
arrived as maternal transports
for pregnancy complications.
Forty three of the cohort were
singletons (89.6%) and 5 were
twins (10.4%) [One corresponding
twin was not transported from the
outlying hospital where delivered].
Interestingly, 37 were male (77.1%)
while 11 were female (22.9%).
Maternal age at delivery ranged
from 18 to 38 years old with an
average age of 26.1 years. Most were

Table 1. Prenatal Care Patterns
PRENATAL CARE

FIRST APPOINTMENT

CONSISTENCY

WOMEN

GOOD CARE

Starting in 1st trimester

No missed appointments

13

LATE CARE

Starting after 1st trimester

+/- missed appointments

4

VERY LATE CARE

Starting after 2nd trimester

+/- missed appointments

9

INCONSISTENT CARE

Starting in 1st trimester

Missed >2 appointments

17

NO CARE

---------------------------------

---------------------------------

2

UNKNOWN CARE

---------------------------------

---------------------------------

1
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in their 20’s (N=36, 78.3%), 9 were
in their 30’s (19.6%) and one was
less than 20 (2.1%). Gravity ranged
from 1 to 12 with an average of
3.1 pregnancies per mother. Parity
ranged from zero to 6 yielding
71 children delivered to this
population previously, of which 15
were preterm (21.1%) and 5 were
documented fetal demises at greater
than 20 weeks gestation (7.0%).
Twenty-nine previous spontaneous
abortions were also reported.
Most mothers were single (N=20,
43.4%), 15 were married (32.6%),
10 were divorced or separated
(21.7%) and one was widowed.
Twenty-one cesarean sections
(45.7%) were performed and
comprised of 12 primary low
transverse, 1 primary classical
and 8 repeat low transverse.
Reasons for caesarian section
included: fetal distress (8), severe
preeclampsia (1), abruption (2),
malpresentation (3), Hepatitis C
(3), twins (3) and unknown (1). The
remaining 25 mothers delivered
vaginally (54.3%) with one requiring
vacuum assistance and another
necessitating forceps. One delivery
was a vaginal birth after cesarean.
The average gestational age
at delivery was 35 6/7 weeks
with a range of 26 0/7 to 42 0/7
weeks (Figure 1). Prenatal care
was frequently either late and/
or inconsistent or no care at all
(Table 1). Eleven mothers were
seen by maternal fetal medicine

and every obstetric practice in
our area was involved in the
care of some of these women.
Opiates were the most common
maternal substance found, while
neonates most often tested positive
for methadone (Figure 2). Drug
test results could not be found for
11 of the mothers and 14 of the
neonates. It was unclear if these
tests were ordered. Negative testing
was identified in 2 mothers and 9
neonates. Seven mothers (15.2%)
readily admitted to using alcohol
during the reference pregnancy,
with one admitting to drinking
“almost every day.” Forty one
mothers smoked (89.1%) while
three denied smoking (6.5%) and
2 were undeterminable (4.3%).
Of the 19 mothers positive for
methadone, 6 were buying the drug
on the street, 2 had prescriptions from
their physicians, while the remaining
11 went to methadone clinics. Eleven
of the 13 were taking methadone due
to a history of narcotic abuse and for
the prevention of withdrawal while
pregnant. The remaining two had
chronic low back pain, both from
motor vehicle accidents. Methadone
doses ranged from 20 mg to 140mg
daily (average dose 98.5mg daily).
Prescription medications other
than methadone were used by 6
mothers. One took oxycodone/
acetaminophen for low back pain
(spinal stenosis), while another
took oxycodone/acetaminophen
for osteoarthritis. One mother

Figure 1.

Gestation at delivery.
25
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10

Number of Neonates
5
2

1
0
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28to336/7

34to366/7
Weeks of Gestation

37to40

Morethan40

was prescribed oxycodone CR
for restless leg syndrome and
another took acetaminophen with
codeine for a childhood sports
injury to her thoracic spine. One
woman took both oxycodone and
alprazolam for chronic pain caused
by an automobile accident and its
provocation of anxiety attacks. The
last took clonazepam for her anxiety.
While none of the mothers
spent excess time in the hospital
postpartum, six spent time on the
antepartum unit. The longest stay
was for 17 days for “fetal well
being” following an ethics consult.
One was directly admitted from
the Emergency Department after
presenting in withdrawal. She stayed
9 days before having an emergent
cesarean section for fetal distress.
Other antepartum admissions
included one for oligohydramnios,
one for preeclampsia, and
two for pre-term labor.
Within this cohort (N=46) there
were numerous complications with
both the pregnancies as well as the
deliveries. Half of these women
went into preterm labor (N=23).
Twelve had premature rupture
of membranes (26.1%) with 9
occurring preterm (19.6%). Many
placental complications were seen
including: abruption (N=6, 13.0%),
previa (N=2), velamentous cord
insertion (N=1), and accreta (N=2)
with one requiring a hysterectomy.
Documentation revealed 5 cases
of chorioamnionitis, 14 cases of
meconium stained amniotic fluid
and 4 cases of oligohydramnios.
Non-reassuring fetal heart tracings
were noted in 15 of the pregnancies
(32.6%). Five precipitous deliveries
occurred—with one delivery at
home. While most of the fetuses
were in the vertex presentation
at delivery (N=42, 91.3%), 5 were
malpositioned. Of these, three were
breech (two frank and one footling),
one was transverse, and one was
direct occiput posterior. Two had
undocumented presentations,
but delivered vaginally.
Neonatal complications were
numerous. By design, all of the
neonates had neonatal abstinence

18   West Virginia Medical Journal

MJ_MarApr_09.indd 18

2/20/2009 10:09:10 AM

| Scientific Article

Figure 2.

Substances involved during the reference pregnancy.
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syndrome (N=48), most of which
were directly related to current or
past use of illicit substances (N=42,
91.3%) (Figure 3). Because of their
dependence, twenty six (54.2%) of
the neonates required weaning with
methadone totaling 215 days with
23 going home on this medication
for continued weaning as an
outpatient. Of these: 11 necessitated
outpatient apnea monitoring as
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well. Thirteen required respiratory
assistance totaling 7 days of high
frequency ventilation, 19 days regular
ventilation, 83 days of continuous
positive airway pressure (CPAP), and
numerous days of oxygen assistance.
Two neonates were lethargic at birth
and one required cardiopulmonary
resuscitation and administration of
naloxone. One was noted to have
elevated liver enzymes caused by in

utero anoxic hepatic injury. Fifteen
other neonates were found to have
hyperbilirubinemia requiring 63
total days of light therapy. One
child had culture proven septicemia
with MRSA, while 21 others had
suspected sepsis, but with negative
cultures. These children were given
IV antibiotics for a total of 127 days.
Thirteen were diagnosed with anemia
of which 5 needed transfusions and
4 received epoetin alfa. Two also
received fresh frozen plasma.
Other serious complications
included intraventicular hemorrhages
(2), bilateral pneumothorax (1),
pulmonary hemorrhage (1), GI bleed
(1), intrauterine growth restriction
(9) and large for gestational age (3)
(Figure 4). In addition to serious
complications there were an unusual
number of anomalies identified
which included distal rectal atresia
(1), peripheral pulmonary artery
branch stenosis (1), microcephaly
(1), syndactyly (2), umbilical/
inguinal hernias (1) and three
failed hearing examinations.
Of the 48 neonates, 40 required
NICU assistance (83.3%) for a total of
650 days (range 1-55 days, average
stay 16.25 days). An additional 36
days were spent in the well child
nursery and 13 days on the pediatric

Figure 3.

Substance Source by Neonate [N=48]: 1)
History of illicit drug abuse now going
to Methadone Clinic, with no evidence
of continued abuse [N=8]. 2) History of
illicit drug abuse now going to Methadone
Clinic and continuing illicit abuse [N=4].
3) Continued illicit abuse [N=27]. 4)
Prescription medication from a physician
and continuing illicit abuse [N=3]. 5)
Prescription medication from a physician,
with no evidence of illicit abuse [N=3].
6) Methadone from a physician [N=2]. 7)
Given long term narcotics in the NICU
for pain relief [N=1].
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Figure 4.

Birth weight expressed as the percentage expected for gestational age at delivery.
N=1,2%

N=3,6%

N=8,17%
N=16,33%

N=20,42%

<5%(SevereIUGR)

5to<10%(IUGR)

50to90%(HighNormal)

>90%(LargeforGestation)

service. Two babies were transported
back to outlying hospitals prior to
discharge. Most of the neonates were
discharged home with their mothers
(N=31, 64.6%), while 5 went with
relatives (usually a grandparent),
11 went to foster care (22.9%) and
one was unknown. Of interest, one
child reported to the emergency
department in cardiopulmonary
arrest just 9 days after being
discharged home with his mother
and grandmother. He had severe
anoxic ischemic encephalopathy
and died 3 days later.
The majority of our patients had
health insurance and were covered
by Medicaid (N=38, 79.2%) most
of which were from West Virginia
(N=22) but neighboring states Ohio
(N=11) and Kentucky (N=5) were
also well represented. Three had
no coverage at delivery, but later
received Medicaid and only a few
had private insurance (N=7, 14.6%).
Total cost for the care of these 48
neonates while hospitalized exceeded
$1,761,582 at an average of $36,700
per child. This figure represents

10to<50%(LowNormal)

hospitalization costs only for the
neonates, not their mothers, and
does not include physician costs.
The hospitalization cost for a healthy
newborn going to the newborn
nursery was determined by averaging
the cost of all such neonates in 2005.
This group had an average stay of
2.3 days at a cost of $1,964.16 each.
The average cost for neonates with
NAS who were otherwise healthy
was then calculated. This group
spent an average of 5 days at a cost
of $5,898.71 each. The difference
between these two groups ($3,934.55)
is the excess charge attributed
to detoxification of one neonate.
Multiplying this amount by 48, (the
number of neonates in our study)
produces $188,858.40 spent in 2005
for detoxification alone. It was not
possible to relate the remaining NICU
costs directly to maternal drug abuse
but an obvious inference can be made
since the rate of NICU admissions
from our cohort is much greater
than that of the general population.
Lastly, review of the raw numbers
of neonates diagnosed with NAS in

the two years prior to 2005 as well as
the two years after 2005 demonstrates
a clear upward trend (Figure 5).

Discussion
All cases of Neonatal Abstinence
Syndrome caused by maternal drug
abuse are preventable. Throughout
history, men and women have used
a wide array of substances to cause
various effects within their bodies
and this experimentation is very
unlikely to change. Unfortunately,
within our pregnant population this
trend is increasing bringing with it
an increase in neonatal morbidity
and mortality as well as increasing
strain on our healthcare system.
Most of the women in our
cohort study received either late
or inconsistent prenatal care with
some receiving no care at all ( Table
#1). Forty-one neonates were either
covered by Medicaid at the time
of delivery or shortly thereafter.
This group represents 85.4% of
our study population indicating
the involvement of socioeconomic
factors. It is essential, however, that
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Figure 5.

Neonates diagnosed with Neonatal Abstinence Syndrome by year. Dashed line shows
trend increasing (binomial regression).
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the physician practicing obstetrics be
mindful that the problems leading to
NAS cross all socioeconomic levels.
The population characterized
in this study ranged from 18 to 38
years of age, which encompasses
the full age range of fertile women.
It is apparent that no age group can
be excluded from scrutiny when
thinking about the possibility of
substance abuse in pregnancy.
The greater majority of those
studied were either single,
separated or divorced (N=30)
indicating a potential lack of
stability and commitment in their
lives. Practitioners need to note
however, that fifteen of the women
were married; once again making it
difficult to determine whom to screen
for potential problems with abuse.
Most drug abusers will not be
identified unless all obstetric patients
are screened. Even then, denial is
a major obstacle, especially in the
pregnant population. Women may
not admit to drug abuse for fear of
loss of custody, legal ramifications,
or guilt. Careful history taking
is important. The interviewer
must be respectful, attentive and
understanding while asking neutral
open-ended questions. It is useful to
begin asking about legal substances

2005

2006

2007

such as cigarette smoking, alcohol
consumption and prescription
medication. Marijuana, while illegal,
carries less social stigma and women
may respond truthfully if asked
about its use. Questions about clearly
illegal substances such as cocaine,
heroin, and methamphetamines
will complete the review.
For each substance, ask the
dosage, frequency and the last
time used. The route of dosage is
important since IV drug abuse is
closely related to infectious diseases,
many of which have serious
consequences for both the mother
and fetus. A history of sharing
needles is particularly worrisome.
Risk factors include late or
inconsistent prenatal care, past
history of spontaneous abortions,
premature birth, growth retardation,
abruptions, precipitous delivery,
or stillbirths. Trouble with law
enforcement, child protective services
involvement, and having children
removed from the home should
raise questions. Family history of
substance abuse as well as substance
abusing spouses, especially in
patients with risk factors of their own,
are especially worrisome since often
a family member or the spouse is the
initiating factor. Mothers of children

with neurological or developmental
problems should also raise concern.
Certain infectious diseases
and illnesses are often associated
with substance abuse. HIV,
hepatitis, endocarditis and sexually
transmitted diseases should raise
questions about IV drug abuse
or trading sex for drugs. Physical
findings such as needle tract marks,
atrophy of the nasal septum,
tachycardia, and abnormalities
of pupil size, diaphoresis, or
behavior that is deemed as
abnormal should raise concern.
Practicing physicians treating
female patients must be cognizant
of the possibility of drug abuse in
pregnancy recognizing that the
problem crosses all socioeconomic,
age and race boundaries. An increase
in awareness leads to opportunities
for early interventions and aggressive
management that in turn leads to
better outcomes. Proper screening
techniques, good history taking
skills and thorough physical
examinations are necessary to alert
the clinician to potential substance
abuse. Risk factors must be evaluated
carefully and tactfully. Once abuse
is identified, it becomes imperative
to develop a treatment plan with
the patient. Special consideration
of the desire to quit, the substance
involved, the dosage, and gestational
age must be considered. With ample
time, psychiatric counseling, and
social services support, almost any
motivated patient can be detoxified.
If any of these requirements are
absent, the mother can be placed
on a methadone maintenance
program with reasonable success,
understanding that the newborn
will require detoxification.
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